RNS Number : 5923P
EKF Diagnostics Holdings PLC
10 June 2020
 

EKF Diagnostics Holdings plc

("EKF" or the "Company")

 

Results of AGM

 

EKF Diagnostics Holdings (AIM: EKF), the AIM quoted point-of-care business, announces that at the Annual General Meeting ("AGM") held earlier today, all resolutions were duly passed.

 

The results of the AGM is available on the Company website: https://www.ekfdiagnostics.com/

 

Enquiries:

 

EKF Diagnostics Holdings plc 

www.ekfdiagnostics.com

Christopher Mills, Non-Executive Chairman

Tel: 029 2071 0570

Julian Baines, CEO 


Richard Evans, FD & COO




N+1 Singer (Nomad & Broker)

Tel: 020 7496 3000

Aubrey Powell / George Tzimas (Corporate Finance)

Tom Salvesen (Corporate Broking)




Walbrook PR Limited                                                                           Tel: 020 7933 8780 or ekf@walbrookpr.com 

Paul McManus/ Lianne Cawthorne

Mob: 07980 541 893 / 07584 391 303

 

 

About EKF Diagnostics Holdings plc (www.ekfdiagnostics.com)

EKF is a leading point-of-care diagnostics and central laboratory assay manufacturer with an estimated 80,000 hemoglobin, hematocrit, HbA1c, glucose and lactate analyzers in regular use across more than 100 countries. EKF specializes in developing tests for use in anemia and diabetes diagnosis and management, as well as providing a portfolio of reagents for use in clinical chemistry analyzers.

 

 



 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGQBLFFBQLXBBX
admin Results of AGM 30777357 A Wed, 06/10/2020 - 17:43 LSE RNS Results and Trading Reports EKF